Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Marta Di Martile

Istituto Regina Elena

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cell Biology

70%

Immunology

40%

Cancer Biology

90%

Apoptosis

40%

Melanoma

30%

B Cell Biology

20%

Phytochemical

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles17

LVI and DI-SPME Combined with GC/MS and GC/MS for Volatile Chemical Profile Investigation and Cytotoxic Power Evaluation of Essential Oil and Hydrolate from <i>Cannabis sativa</i> L. cv. Carmagnola.

Article Link

Year:

2024

Bcl-2 dependent modulation of Hippo pathway in cancer cells.

Article Link

Year:

2024

Phytochemicals as Immunomodulatory Agents in Melanoma

Article Link

Year:

2023

Volatile and Non-Volatile Content Determination and Biological Activity Evaluation of Fresh <i>Humulus lupulus</i> L. (cv. Chinook) Leaves and Inflorescences

Article Link

Year:

2023

Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment

Article Link

Year:

2023

Caspase-8 as a novel mediator linking Src kinase signaling to enhanced glioblastoma malignancy

Article Link

Year:

2023

Bcl-2 family inhibitors sensitize human cancer models to therapy

Article Link

Year:

2023

Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.

Article Link

Year:

2023

Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules

Article Link

Year:

2022

SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma.

Article Link

Year:

2022

Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance.

Article Link

Year:

2022

SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia

Article Link

Year:

2021

Antitumor effect of Melaleuca alternifolia essential oil and its main component terpinen-4-ol in combination with target therapy in melanoma models

Article Link

Year:

2021

Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells

Article Link

Year:

2020

Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma

Article Link

Year:

2020

Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages

Article Link

Year:

2020

microRNA-378a-5p iS a novel positive regulator of melanoma progression

Article Link

Year:

2020

Collaborators9

Carlo Mischiati

Associate Professor

University of Ferrara

ITALY

Marcello Iriti

University of Milan

ITALY

Donatella Del Bufalo

Istituto Regina Elena

ITALY

Lorenzo Antonini

Sapienza University of Rome

ITALY

Simona D'Aguanno

Istituto Regina Elena

ITALY

Rossella Loria

Istituto Regina Elena

ITALY

Massimiliano Andreazzoli

University of Pisa

ITALY

Isabella Sperduti

Istituto Regina Elena

ITALY

Sara Vitalini

Università degli Studi di Torino

ITALY

How do I reach out?

Meet Kite AI